What does the mass spectrometry section of a Certificate of Analysis actually report?
A Certificate of Analysis (CoA) for a research compound typically presents mass spectrometry data as a short block: a theoretical mass calculated from the compound's molecular formula, an observed (or "found") mass measured by the instrument, and sometimes a peak table listing individual detected ions. This block answers a narrow but load-bearing question — does the material in the vial weigh what the stated compound should weigh — and it is distinct from the HPLC purity percentage reported elsewhere on the same document. Purity tells a researcher how much of the sample is the dominant species; mass spectrometry tells a researcher what that dominant species actually is.
Reading this section correctly requires understanding four things: how the instrument that generated the numbers was calibrated, how to parse a peak table when one is provided, why small molecules and peptides produce visibly different spectra, and what tolerance separates a passing identity confirmation from a batch that needs further investigation. This guide walks through each in turn, using compounds across Valitec's own catalog — spanning small molecules such as AICAR and SLU-PP-332 through mid-sized and larger peptides such as Semax and Tesamorelin — as worked reference points.
How is the instrument calibrated, and why does that matter for the numbers on the CoA?
A mass spectrometer does not measure mass directly; it measures the time, trajectory, or frequency behavior of ions in a field, and converts that measurement to a mass-to-charge (m/z) value through a calibration function established against reference standards of known mass. External calibration runs a set of reference compounds spanning the relevant mass range before the analytical batch, generating a calibration curve that the instrument software applies to subsequent unknown-sample measurements. Internal calibration introduces a reference compound directly into the sample run, providing a calibration point measured under identical conditions to the analyte itself, which generally yields tighter accuracy than external calibration alone.
Instrument-grade analytical documentation traces this calibration chain explicitly: which reference standards were used, when the calibration was last performed, and what mass accuracy the calibration achieved across the relevant mass range. A CoA that reports only a bare observed mass, with no indication of calibration traceability, gives a researcher less basis for trusting that number than one that documents the calibration standard and the instrument's demonstrated accuracy at the time of the run. This distinction is why instrument-grade characterization treats calibration documentation as part of the identity confirmation, not a background detail — a well-calibrated instrument measuring the wrong compound will still report a precise, confident, and wrong number.
How do you read the peak table: m/z, charge state, and calculated mass?
When a CoA includes a peak table rather than a single summary number, each row typically lists an observed m/z value, an inferred charge state, and a calculated neutral mass derived from those two figures. For a singly charged ion — written [M+H]⁺ — the observed m/z is approximately the neutral molecular weight plus the mass of one proton (about 1.007 Da). For a doubly charged ion [M+2H]²⁺, the m/z is approximately (neutral mass + 2 × 1.007) / 2.
Take AICAR, carrying CAS number 2627-69-2, molecular formula C9H14N4O5, and a molecular weight of 258.23 g/mol. As a small molecule ionizing predominantly as a singly charged species, its CoA peak table would show an [M+H]⁺ ion at approximately m/z 259.2. There is no charge-state deconvolution required — the observed peak sits close to the theoretical mass plus one proton, and the calculated mass column simply subtracts that proton mass back out.
Contrast this with Tesamorelin, carrying CAS number 218949-48-5, molecular formula C221H366N68O66S, and a molecular weight of 5135.89 g/mol. A peptide of this size ionizes as a distribution of multiply charged species under electrospray conditions — a peak table might list [M+4H]⁴⁺, [M+5H]⁵⁺, and [M+6H]⁶⁺ ions at distinct m/z values, each of which the instrument software deconvolutes back to the same calculated neutral mass near 5135.9 Da. When a CoA reports several peaks that all resolve to the same calculated mass, that convergence across charge states is itself supporting evidence of correct identity — an artifact or contaminant peak would not typically reproduce the same deconvoluted mass at multiple charge states.
Why do small molecules and peptides produce different-looking mass spectra?
The visual character of a mass spectrum tracks compound size and structure in a predictable way, and knowing what to expect for a given compound class helps a researcher sanity-check a CoA at a glance. Small molecules — AICAR at 258.23 g/mol or SLU-PP-332, carrying CAS number 2155854-26-3 and a molecular weight of 393.37 g/mol — typically produce a simple spectrum dominated by a single [M+H]⁺ peak, sometimes accompanied by a smaller sodium or potassium adduct peak, with minimal charge-state complexity.
Mid-sized peptides such as Semax, carrying CAS number 80714-61-0, molecular formula C37H51N9O10S, and a molecular weight of 813.93 g/mol, sit at a transition point — they can appear as a dominant [M+H]⁺ singly charged peak, a [M+2H]²⁺ doubly charged peak, or both, depending on the ionization conditions and the peptide's basic residue content. Larger peptides such as Tesamorelin, at over 5100 Da, reliably produce the multi-peak charge-state envelope described in the previous section, because a molecule of that size cannot practically carry enough net positive charge in a single-proton state to fall within a standard mass analyzer's detection range at reasonable sensitivity.
Recognizing which pattern a given compound class should produce is a useful independent check: a small molecule CoA showing an unexplained multi-peak charge envelope, or a large peptide CoA showing only a single low-charge-state peak with no supporting higher-charge-state peaks, is a mismatch worth investigating rather than assuming the software's summary number is correct by default.
What do adduct peaks and background noise tell you about data quality?
Beyond the primary protonated ion, a mass spectrum commonly shows smaller adduct peaks — sodium adducts [M+Na]⁺ appearing roughly 22 Da above the [M+H]⁺ peak, and potassium adducts [M+K]⁺ roughly 38 Da above it. These form when trace sodium or potassium ions associate with the analyte during ionization rather than a proton doing so. Their presence at low relative intensity is normal; at high relative intensity, comparable to or exceeding the main peak, it can indicate elevated salt content in the sample preparation.
Background noise — signal not attributable to the analyte, calibration standard, or expected adducts — is the other data-quality signal worth reading on an included spectrum image. A clean spectrum shows a well-resolved analyte peak cluster rising clearly above a flat, low baseline. A noisy baseline or unexplained secondary peaks reduce confidence in the reported identity match, even when the summary theoretical-versus-observed comparison technically falls within tolerance. A CoA that includes the underlying spectrum image gives a researcher the ability to make this assessment directly, instead of relying entirely on the reported pass/fail outcome.
How is mass accuracy expressed, and what tolerance is acceptable?
Mass accuracy on a CoA is typically expressed either as an absolute mass difference in Daltons or as a relative difference in parts per million (ppm). The relationship between the two depends on compound size: a fixed absolute tolerance of ±0.5 Da represents a much tighter relative tolerance for a small molecule like AICAR (258.23 g/mol) than for a peptide like Tesamorelin (5135.89 g/mol), because ±0.5 Da is a larger fraction of the smaller molecule's total mass.
Standard-resolution instruments used in routine research-compound QC commonly report accuracy within ±0.5 Da or better across the compound classes in this catalog. High-resolution mass spectrometers — typically time-of-flight or Orbitrap-based systems — can achieve accuracy in the low single-digit ppm range, which for a compound in the 200–1000 Da range translates to well under ±0.01 Da. When a CoA states a tolerance, that number should be read against the compound's own mass: a ±0.3 Da deviation on a 258 Da small molecule is a materially larger relative error than the same absolute deviation on a 5136 Da peptide, even though both fall within a fixed ±0.5 Da specification.
A deviation that falls outside the stated tolerance is not automatically evidence of the wrong compound — synthesis-related structural modifications, incomplete deprotection, oxidation, or an unaccounted adduct can all produce an out-of-tolerance result for a genuinely correct compound that simply needs a corrected theoretical-mass calculation. But an out-of-tolerance result on a routine, unmodified compound with a straightforward molecular formula warrants investigation before the batch is accepted as identity-confirmed.
What red flags in a mass spec section should prompt further scrutiny?
Several patterns on a CoA's mass spectrometry section warrant a closer look. A summary presenting only "mass confirmed" with no numeric theoretical or observed value provides no basis for independent verification. A reported mass accuracy far outside what the stated instrument type and resolution class should be capable of — a low-resolution quadrupole instrument claiming single-digit-ppm accuracy, for instance — is inconsistent with typical instrument performance and worth questioning.
A missing charge-state explanation for a peptide well above roughly 1500–2000 Da, where a single-charge-state result is analytically unusual, is another pattern worth flagging. A CoA that reports average (chemical) mass without stating so, compared against a database value calculated as monoisotopic mass, can produce an apparent multi-Dalton discrepancy reflecting a units mismatch rather than a real identity problem. The underlying principle is the same throughout: a CoA that provides enough detail for a researcher to check the arithmetic independently is a stronger document than one that provides only a conclusion.
How does Valitec document mass spectrometry data across the catalog?
Valitec's analytical documentation standard reports both theoretical and observed mass on every compound CoA, calculated against the molecular formula and molecular weight values maintained in the compound specification for each catalog entry — including small molecules such as AICAR and SLU-PP-332 and peptides across the size range represented by Semax and Tesamorelin. Calibration traceability and instrument resolution class are documented alongside the mass result, and mass spectrometry data is reported as a distinct analytical parameter from HPLC purity, consistent with the two-method identity-and-purity standard described in the research compound sourcing documentation article.
For compounds intended for cell-based research applications, mass spectrometry identity confirmation is documented alongside batch-specific endotoxin testing where applicable, covered in more detail in the endotoxin testing overview. Researchers can review current molecular specifications, available sizes, and CoA documentation on individual compound pages, or browse the full research catalog. All material is intended for laboratory research use only.
All compounds supplied by Valitec Peptides are research chemicals intended for laboratory and scientific research purposes only. They are not drugs, supplements, or food products, and are not intended to diagnose, treat, cure, or prevent any disease. Valitec Peptides does not supply products for human or animal use. Researchers are responsible for compliance with all applicable local, state, and federal regulations governing the purchase and use of research materials.
